Clinical Trials
893 trialsA Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Compugen Ltd
Single-stapled Double Purse-string Technique for Colorectal Anastomosis
Vejle Hospital
COMPANION-003
Compass Therapeutics
CHALLENGE
Canadian Cancer Trials Group
EMOTION
Centre Antoine Lacassagne
DOCC
University Hospital, Rouen
Comparison of the Left-Lateral Horizontal and Supine Positions for Colonoscopy Intervention: A Randomized Controlled Study
Celal Bayar University
DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer
Maltepe University
Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative
H. Lee Moffitt Cancer Center and Research Institute
COLOCROSS
Centre Oscar Lambret
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
00-046
Memorial Sloan Kettering Cancer Center
EHCancer
Zagazig University
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Intima Bioscience, Inc.
Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer
Institute of Oncology Ljubljana
Using Visual Arrays to Support Understanding of Genetic Risk
Massachusetts General Hospital
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
SWOG Cancer Research Network
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Roswell Park Cancer Institute
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
M.D. Anderson Cancer Center
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
Ballad Health
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt
Sohag University
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
PICoC
The Royal Wolverhampton Hospitals NHS Trust
TAP
Trinity Health Michigan
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
City of Hope Medical Center
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
M.D. Anderson Cancer Center
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
University of California, San Francisco
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
PeLear CCC
University of North Carolina, Chapel Hill
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
MU-PRIOR
Erasmus Medical Center
Edrecolomab in Treating Patients With Stage II Colon Cancer
National Cancer Institute (NCI)
Efficacy and Safety of Supervised Therapeutic Exercise in Cancer Patients With and Without Concurrent Treatment.
Universidad Complutense de Madrid
Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the NYU FHCs
NYU Langone Health
SUCCEED
University of California, San Francisco
Study of Colorectal Cancer Screening Options
Kaiser Permanente
DA-CRC
University of Pavia
NEFOPAM
Centre Hospitalier Universitaire de Nīmes
QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
NantCell, Inc.
High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients
Zhejiang University
MindCRC
University of Illinois at Chicago
Evaluation the of Role of Vitamin D Supplement on Tumor Response, Inflammation and Apoptosis in Patients With Stage II or III Colorectal Cancer Receiving Chemotherapy.
Tanta University
IROCAS
UNICANCER
IMPACTT
Vejle Hospital
AYAConnect
UNC Lineberger Comprehensive Cancer Center
CALM: Managing Distress in Malignant Brain Cancer
Virginia Commonwealth University
NeoBRAF
AIO-Studien-gGmbH